Monalizumab and Trastuzumab In Metastatic HER2-pOSitive breAst Cancer: MIMOSA-trial
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: Monalizumab|BIOLOGICAL: Trastuzumab
Sponsor: The Netherlands Cancer Institute
Collaborators: AstraZeneca